Genetic Aspects of Non-Alcoholic Fatty Liver Disease

Non-alcoholic fatty liver disease (NAFLD) is the most commonly diagnosed hepatopathy. There is an increase in the incidence of NAFLD in the structure of liver diseases in children and adolescents, which is directly related to the increasing prevalence of obesity. The spectrum of liver tissue changes...

Full description

Saved in:
Bibliographic Details
Main Authors: Pavel O. Bogomolov, Kseniya Yu. Kokina, Aleksander Yu. Mayorov, Ekaterina E. Mishina
Format: Article
Language:English
Published: "Paediatrician" Publishers LLC 2019-01-01
Series:Вопросы современной педиатрии
Subjects:
Online Access:https://vsp.spr-journal.ru/jour/article/view/1975
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1849411685821972480
author Pavel O. Bogomolov
Kseniya Yu. Kokina
Aleksander Yu. Mayorov
Ekaterina E. Mishina
author_facet Pavel O. Bogomolov
Kseniya Yu. Kokina
Aleksander Yu. Mayorov
Ekaterina E. Mishina
author_sort Pavel O. Bogomolov
collection DOAJ
description Non-alcoholic fatty liver disease (NAFLD) is the most commonly diagnosed hepatopathy. There is an increase in the incidence of NAFLD in the structure of liver diseases in children and adolescents, which is directly related to the increasing prevalence of obesity. The spectrum of liver tissue changes in NAFLD ranges from benign hepatocellular steatosis to non-alcoholic steatohepatitis (NASH), fibrosis, cirrhosis of the liver, and hepatocellular carcinoma. With the increasing prevalence of NAFLD in children, we can expect an increase in the incidence of adverse outcomes among people of working age. The key problem for NAFLD is the prediction of disease outcomes. In epidemiological and genetic studies, the relationship between the morphological stage of NAFLD and hereditary factors is shown. Currently, there are three genes associated with NAFLD (PNPLA3, TM6SF2, and GCKR), which, together with the genes responsible for insulin resistance, lipid deposition, inflammation and fibrogenesis in hepatocytes, determine the phenotype of fatty liver disease. The article considers the modern understanding of the issues of genetics, development of liver steatosis and progression of NASH. It is expected that this knowledge can transform our risk stratification strategies in patients with NAFLD and help identify new therapeutic goals.
format Article
id doaj-art-ddb3d5f49ca94b46af367624ee18177e
institution Kabale University
issn 1682-5527
1682-5535
language English
publishDate 2019-01-01
publisher "Paediatrician" Publishers LLC
record_format Article
series Вопросы современной педиатрии
spelling doaj-art-ddb3d5f49ca94b46af367624ee18177e2025-08-20T03:34:41Zeng"Paediatrician" Publishers LLCВопросы современной педиатрии1682-55271682-55352019-01-0117644244810.15690/vsp.v17i6.19741788Genetic Aspects of Non-Alcoholic Fatty Liver DiseasePavel O. Bogomolov0Kseniya Yu. Kokina1Aleksander Yu. Mayorov2Ekaterina E. Mishina3Vladimirsky Moscow Regional Research Clinical InstituteVladimirsky Moscow Regional Research Clinical InstituteNational Medical Research Centre of Endocrinology,National Medical Research Centre of Endocrinology,Non-alcoholic fatty liver disease (NAFLD) is the most commonly diagnosed hepatopathy. There is an increase in the incidence of NAFLD in the structure of liver diseases in children and adolescents, which is directly related to the increasing prevalence of obesity. The spectrum of liver tissue changes in NAFLD ranges from benign hepatocellular steatosis to non-alcoholic steatohepatitis (NASH), fibrosis, cirrhosis of the liver, and hepatocellular carcinoma. With the increasing prevalence of NAFLD in children, we can expect an increase in the incidence of adverse outcomes among people of working age. The key problem for NAFLD is the prediction of disease outcomes. In epidemiological and genetic studies, the relationship between the morphological stage of NAFLD and hereditary factors is shown. Currently, there are three genes associated with NAFLD (PNPLA3, TM6SF2, and GCKR), which, together with the genes responsible for insulin resistance, lipid deposition, inflammation and fibrogenesis in hepatocytes, determine the phenotype of fatty liver disease. The article considers the modern understanding of the issues of genetics, development of liver steatosis and progression of NASH. It is expected that this knowledge can transform our risk stratification strategies in patients with NAFLD and help identify new therapeutic goals.https://vsp.spr-journal.ru/jour/article/view/1975non-alcoholic fatty liver diseasenon-alcoholic steatohepatitisgenotypingpnpla3 genemboat7 genetm6sf2 genegckr gene
spellingShingle Pavel O. Bogomolov
Kseniya Yu. Kokina
Aleksander Yu. Mayorov
Ekaterina E. Mishina
Genetic Aspects of Non-Alcoholic Fatty Liver Disease
Вопросы современной педиатрии
non-alcoholic fatty liver disease
non-alcoholic steatohepatitis
genotyping
pnpla3 gene
mboat7 gene
tm6sf2 gene
gckr gene
title Genetic Aspects of Non-Alcoholic Fatty Liver Disease
title_full Genetic Aspects of Non-Alcoholic Fatty Liver Disease
title_fullStr Genetic Aspects of Non-Alcoholic Fatty Liver Disease
title_full_unstemmed Genetic Aspects of Non-Alcoholic Fatty Liver Disease
title_short Genetic Aspects of Non-Alcoholic Fatty Liver Disease
title_sort genetic aspects of non alcoholic fatty liver disease
topic non-alcoholic fatty liver disease
non-alcoholic steatohepatitis
genotyping
pnpla3 gene
mboat7 gene
tm6sf2 gene
gckr gene
url https://vsp.spr-journal.ru/jour/article/view/1975
work_keys_str_mv AT pavelobogomolov geneticaspectsofnonalcoholicfattyliverdisease
AT kseniyayukokina geneticaspectsofnonalcoholicfattyliverdisease
AT aleksanderyumayorov geneticaspectsofnonalcoholicfattyliverdisease
AT ekaterinaemishina geneticaspectsofnonalcoholicfattyliverdisease